CleveMed, Cleveland, OH – April 23, 2023 – CleveMed, a leader in Home Sleep Testing (HST) technology and services announced that its data security policies and procedures successfully met the high-quality ISO 27001 standard. The ISO 27001 is the world’s best-known standard for information security management systems (ISMS) and is often required as part of vendor selection processes. Certification was conducted by a world-renowned independent accreditation agency (British Standards Institution – BSI) following a comprehensive audit of the requirements outlined within its framework.
CleveMed is a trusted partner to health systems across the country offering sleep apnea monitoring technologies and services to thousands of patients every month with all patient data aggregating on the cloud. “We take the confidentiality and security of patient data very seriously. Receiving the ISO 27001 certificate is an independent testament of our commitment to the highest data security standards”, said Sarah Weimer, CleveMed’s Sr. Director of Sleep Products and Services. “We are very proud of this accomplishment”.
“We believe in the continued central role of online data management and storage in facilitating the workflow and in improving access to sleep care. Combined with ACHC accreditation, this ISO 27001 certificate further cements CleveMed’s role in the future of sleep medicine”, said Hani Kayyali, President and CEO of CleveMed.
Sleep apnea is a repeated interruption of normal breathing during sleep due to a collapse of the upper airway or loss of central drive. It is estimated to impact as many people as asthma and diabetes; yet, up to 80 percent of the population with the disease remain undiagnosed and untreated. Moreover, sleep apnea leads to serious health and economic consequences. Numerous studies link OSA to major chronic diseases, such as stroke, heart failure, diabetes, obesity, hypertension and increased odds of serious vehicle crash injuries.
CleveMed is a fast growing company with a wide range of sleep testing equipment, services, and web-based technologies that allow sleep disorders to be monitored in the home, including Sapphire PSG™, SleepView®, SleepViewSM Web-portal, and SleepView Direct. CleveMed’s goal is to expand the reach of sleep medicine with technologies that speed diagnosis for providers, reduce healthcare costs for payers, and improve patients’ experiences in the home. For more information, please visit www.CleveMed.com (Follow us on twitter, youtube, LinkedIn, and facebook). SleepView is a registered trademark and a service mark, and Sapphire PSG is a trademark of Cleveland Medical Devices Inc. of Cleveland, OH.